CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
about
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment.Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors.Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site
P2860
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
@en
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
@nl
type
label
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
@en
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
@nl
prefLabel
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
@en
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
@nl
P2860
P1476
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
@en
P2093
Carolin Blattner
Viktor Umansky
P2860
P2888
P304
P356
10.1007/S00262-017-1988-9
P577
2017-04-05T00:00:00Z